Cargando…
Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Massachusetts Medical Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121452/ https://www.ncbi.nlm.nih.gov/pubmed/32227760 http://dx.doi.org/10.1056/NEJMsr2005760 |
_version_ | 1783515205373788160 |
---|---|
author | Vaduganathan, Muthiah Vardeny, Orly Michel, Thomas McMurray, John J.V. Pfeffer, Marc A. Solomon, Scott D. |
author_facet | Vaduganathan, Muthiah Vardeny, Orly Michel, Thomas McMurray, John J.V. Pfeffer, Marc A. Solomon, Scott D. |
author_sort | Vaduganathan, Muthiah |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7121452 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Massachusetts Medical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-71214522020-04-06 Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19 Vaduganathan, Muthiah Vardeny, Orly Michel, Thomas McMurray, John J.V. Pfeffer, Marc A. Solomon, Scott D. N Engl J Med Special Report Massachusetts Medical Society 2020-03-30 /pmc/articles/PMC7121452/ /pubmed/32227760 http://dx.doi.org/10.1056/NEJMsr2005760 Text en Copyright © 2020 Massachusetts Medical Society. All rights reserved. This article is made available via the PMC Open Access Subset for unrestricted re-use, except commercial resale, and analyses in any form or by any means with acknowledgment of the original source. These permissions are granted for the duration of the Covid-19 pandemic or until revoked in writing. Upon expiration of these permissions, PMC is granted a license to make this article available via PMC and Europe PMC, subject to existing copyright protections. |
spellingShingle | Special Report Vaduganathan, Muthiah Vardeny, Orly Michel, Thomas McMurray, John J.V. Pfeffer, Marc A. Solomon, Scott D. Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19 |
title | Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19 |
title_full | Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19 |
title_fullStr | Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19 |
title_full_unstemmed | Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19 |
title_short | Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19 |
title_sort | renin–angiotensin–aldosterone system inhibitors in patients with covid-19 |
topic | Special Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121452/ https://www.ncbi.nlm.nih.gov/pubmed/32227760 http://dx.doi.org/10.1056/NEJMsr2005760 |
work_keys_str_mv | AT vaduganathanmuthiah reninangiotensinaldosteronesysteminhibitorsinpatientswithcovid19 AT vardenyorly reninangiotensinaldosteronesysteminhibitorsinpatientswithcovid19 AT michelthomas reninangiotensinaldosteronesysteminhibitorsinpatientswithcovid19 AT mcmurrayjohnjv reninangiotensinaldosteronesysteminhibitorsinpatientswithcovid19 AT pfeffermarca reninangiotensinaldosteronesysteminhibitorsinpatientswithcovid19 AT solomonscottd reninangiotensinaldosteronesysteminhibitorsinpatientswithcovid19 |